Proprietary AI analyst is now available

Monash IVF Group Valuation Multiples

Discover Monash IVF Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Clinica Las Condes, Goodwill Pharma, Athens Medical Centre, Limes Schlosskliniken and more.

Monash IVF Group Overview

About Monash IVF Group

Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women’s health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.


Founded

2014

HQ

Australia

Employees

889

Financials (LTM)

Revenue: $187M
EBITDA: $40M

EV

$324M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Monash IVF Group Financials

Monash IVF Group reported last 12-month revenue of $187M and EBITDA of $40M.

In the same LTM period, Monash IVF Group generated $131M in gross profit, $40M in EBITDA, and $13M in net income.

Revenue (LTM)


Monash IVF Group P&L

In the most recent fiscal year, Monash IVF Group reported revenue of $192M and EBITDA of $45M.

Monash IVF Group is profitable as of last fiscal year, with gross margin of 89%, EBITDA margin of 23%, and net margin of 9%.

See analyst estimates for Monash IVF Group
LTMLast FY202320242025202620272028
Revenue$187M$192M$166M$186M$190M
Gross Profit$131M$171M$148M$167M$151M
Gross Margin70%89%90%89%80%
EBITDA$40M$45M$20M$26M$42M
EBITDA Margin21%23%12%14%22%
EBIT Margin12%16%6%7%14%
Net Profit$13M$18M$5M$7M$15M
Net Margin7%9%3%4%8%
Net Debt-$63M---

Financial data powered by Morningstar, Inc.

Monash IVF Group Stock Performance

Monash IVF Group has current market cap of $190M, and enterprise value of $324M.

Market Cap Evolution


Monash IVF Group's stock price is $0.49.

Monash IVF Group share price decreased by 4.6% in the last 30 days, and by 2.6% in the last year.

Monash IVF Group has an EPS (earnings per share) of $0.05.

See more trading valuation data for Monash IVF Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$324M$190M-2.2%-4.6%3.0%-2.6%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Monash IVF Group Valuation Multiples

Monash IVF Group trades at 1.7x EV/Revenue multiple, and 8.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Monash IVF Group

EV / Revenue (LTM)


Monash IVF Group Financial Valuation Multiples

As of June 17, 2026, Monash IVF Group has market cap of $190M and EV of $324M.

Monash IVF Group has a P/E ratio of 14.7x.

LTMLast FY202320242025202620272028
EV/Revenue1.7x1.7x2.0x1.7x1.7x
EV/EBITDA8.2x7.3x16.0x12.4x7.7x
EV/EBIT14.2x10.4x33.3x23.8x12.0x
EV/Gross Profit2.5x1.9x2.2x1.9x2.1x
P/E14.7x10.7x35.1x29.1x12.5x
EV/FCF26.6xn/m21.7x31.3x55.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Monash IVF Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Monash IVF Group Margins & Growth Rates

Monash IVF Group decreased revenue by 2% and EBITDA by 11% in the last fiscal year.

In the most recent fiscal year, Monash IVF Group reported gross margin of 89%, EBITDA margin of 23%, and net margin of 9%.

See estimated margins and future growth rates for Monash IVF Group

Monash IVF Group Margins

Last FY202420252026202720282029
Gross Margin89%89%80%70%
EBITDA Margin23%14%22%22%
EBIT Margin16%7%14%12%
Net Margin9%4%8%7%
FCF Margin(1%)6%3%9%

Monash IVF Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)12%2%1%
Gross Profit Growth(24%)12%(9%)(12%)
EBITDA Growth(11%)29%61%(2%)
EBIT Growth(28%)40%97%(12%)
Net Profit Growth(29%)21%133%(12%)
FCF Growth(1277%)(30%)(44%)208%

Data powered by FactSet, Inc. and Morningstar, Inc.

Monash IVF Group Operational KPIs

Monash IVF Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Monash IVF Group's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Monash IVF Group's Rule of X is 23% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Monash IVF Group
LTMLast FY202320242025202620272028
Rule of 4025%22%---
Bessemer Rule of X31%23%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-3%3%3%3%
G&A Expenses to Revenue-36%35%35%36%
Opex to Revenue-73%84%82%74%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Monash IVF Group Competitors

Monash IVF Group competitors include Clinica Las Condes, Goodwill Pharma, Athens Medical Centre, Limes Schlosskliniken, MediClin, Centrum Medyczne ENEL-MED, Suraksha Diagnostics, Atrys Health, Humana and Hyperfine.

Most Monash IVF Group public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Clinica Las Condes2.7x-(5.8x)-
Goodwill Pharma2.9x-10.7x-
Athens Medical Centre1.1x-10.9x-
Limes Schlosskliniken2.8x2.5x11.1x9.7x
MediClin0.5x0.5x3.5x3.7x
Centrum Medyczne ENEL-MED1.0x-7.9x-
Suraksha Diagnostics4.9x5.1x15.3x16.3x
Atrys Health2.7x2.7x19.0x17.2x

This data is available for Pro users. Sign up to see all Monash IVF Group competitors and their valuation data.

Start Free Trial

Acquisitions by Monash IVF Group

Monash IVF Group has acquired 1 company to date.

Last acquisition by Monash IVF Group was on December 19th 2023. Monash IVF Group acquired Fertility North for $15M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Monash IVF Group

Fertility North
Description
Fertility North is a Cairns-based fertility clinic in Queensland, Australia, providing comprehensive infertility treatments including IVF, ICSI, mini IVF, ovulation induction, artificial insemination, surgical sperm collection, and frozen embryo transfer. The clinic serves patients throughout North Queensland with advanced reproductive technologies and personalized care protocols. Established to address regional access challenges, it integrates diagnostic services like ultrasound monitoring and genetic counseling into its offerings.
HQ CountryAustralia
HQ City
Perth
Deal Date19 Dec 2023
Valuation$15M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Monash IVF Group acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Monash IVF Group

When was Monash IVF Group founded?Monash IVF Group was founded in 2014.
Where is Monash IVF Group headquartered?Monash IVF Group is headquartered in Australia.
How many employees does Monash IVF Group have?As of today, Monash IVF Group has over 889 employees.
Is Monash IVF Group publicly listed?Yes, Monash IVF Group is a public company listed on Australian Securities Exchange.
What is the stock symbol of Monash IVF Group?Monash IVF Group trades under MVF ticker.
When did Monash IVF Group go public?Monash IVF Group went public in 2014.
Who are competitors of Monash IVF Group?Monash IVF Group main competitors include Clinica Las Condes, Goodwill Pharma, Athens Medical Centre, Limes Schlosskliniken, MediClin, Centrum Medyczne ENEL-MED, Suraksha Diagnostics, Atrys Health, Humana, Hyperfine.
What is the current market cap of Monash IVF Group?Monash IVF Group's current market cap is $190M.
What is the current revenue of Monash IVF Group?Monash IVF Group's last 12 months revenue is $187M.
What is the current revenue growth of Monash IVF Group?Monash IVF Group revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Monash IVF Group?Current revenue multiple of Monash IVF Group is 1.7x.
What is the current EBITDA of Monash IVF Group?Monash IVF Group's last 12 months EBITDA is $40M.
What is Monash IVF Group's EBITDA margin?Monash IVF Group's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Monash IVF Group?Current EBITDA multiple of Monash IVF Group is 8.2x.
What is the current FCF of Monash IVF Group?Monash IVF Group's last 12 months FCF is $12M.
What is Monash IVF Group's FCF margin?Monash IVF Group's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Monash IVF Group?Current FCF multiple of Monash IVF Group is 26.6x.
How many companies Monash IVF Group has acquired to date?As of June 2026, Monash IVF Group has acquired 1 company.
What was the largest acquisition by Monash IVF Group?$15M acquisition of Fertility North on 19th December 2023 was the largest M&A Monash IVF Group has done to date.
What companies Monash IVF Group acquired?Monash IVF Group acquired Fertility North.
In how many companies Monash IVF Group has invested to date?Monash IVF Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Monash IVF Group

Lists including Monash IVF Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial